(Q60637515)
Statements
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study (English)
P Potepan
F Crippa
P Casieri
M Orsenigo
M Losa
C Liberatoscioli
R G Calderone
G Rinaldi
18 September 2008